Copyright Reports & Markets. All rights reserved.

Global Nanoparticles Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Nanoparticles Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Liposomes
      • 1.4.3 Polymer-Conjugated Drugs
      • 1.4.4 Polymeric Nanoparticles
      • 1.4.5 Dendrimers
      • 1.4.6 Inorganic Nanoparticles
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Nanoparticles Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgery Centers
      • 1.5.4 Diagnostic Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Nanoparticles Market Size
    • 2.2 Nanoparticles Growth Trends by Regions
      • 2.2.1 Nanoparticles Market Size by Regions (2014-2025)
      • 2.2.2 Nanoparticles Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Nanoparticles Market Size by Manufacturers
      • 3.1.1 Global Nanoparticles Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Nanoparticles Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Nanoparticles Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nanoparticles Key Players Head office and Area Served
    • 3.3 Key Players Nanoparticles Product/Solution/Service
    • 3.4 Date of Enter into Nanoparticles Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Nanoparticles Market Size by Type (2014-2019)
    • 4.2 Global Nanoparticles Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Nanoparticles Market Size (2014-2019)
    • 5.2 Nanoparticles Key Players in United States
    • 5.3 United States Nanoparticles Market Size by Type
    • 5.4 United States Nanoparticles Market Size by Application

    6 Europe

    • 6.1 Europe Nanoparticles Market Size (2014-2019)
    • 6.2 Nanoparticles Key Players in Europe
    • 6.3 Europe Nanoparticles Market Size by Type
    • 6.4 Europe Nanoparticles Market Size by Application

    7 China

    • 7.1 China Nanoparticles Market Size (2014-2019)
    • 7.2 Nanoparticles Key Players in China
    • 7.3 China Nanoparticles Market Size by Type
    • 7.4 China Nanoparticles Market Size by Application

    8 Japan

    • 8.1 Japan Nanoparticles Market Size (2014-2019)
    • 8.2 Nanoparticles Key Players in Japan
    • 8.3 Japan Nanoparticles Market Size by Type
    • 8.4 Japan Nanoparticles Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Nanoparticles Market Size (2014-2019)
    • 9.2 Nanoparticles Key Players in Southeast Asia
    • 9.3 Southeast Asia Nanoparticles Market Size by Type
    • 9.4 Southeast Asia Nanoparticles Market Size by Application

    10 India

    • 10.1 India Nanoparticles Market Size (2014-2019)
    • 10.2 Nanoparticles Key Players in India
    • 10.3 India Nanoparticles Market Size by Type
    • 10.4 India Nanoparticles Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Nanoparticles Market Size (2014-2019)
    • 11.2 Nanoparticles Key Players in Central & South America
    • 11.3 Central & South America Nanoparticles Market Size by Type
    • 11.4 Central & South America Nanoparticles Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Nanoparticles Introduction
      • 12.1.4 Novartis Revenue in Nanoparticles Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Gilead Sciences
      • 12.2.1 Gilead Sciences Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Nanoparticles Introduction
      • 12.2.4 Gilead Sciences Revenue in Nanoparticles Business (2014-2019)
      • 12.2.5 Gilead Sciences Recent Development
    • 12.3 Johnson & Johnson
      • 12.3.1 Johnson & Johnson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Nanoparticles Introduction
      • 12.3.4 Johnson & Johnson Revenue in Nanoparticles Business (2014-2019)
      • 12.3.5 Johnson & Johnson Recent Development
    • 12.4 Amgen
      • 12.4.1 Amgen Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Nanoparticles Introduction
      • 12.4.4 Amgen Revenue in Nanoparticles Business (2014-2019)
      • 12.4.5 Amgen Recent Development
    • 12.5 Sigma-Tau Pharmaceuticals
      • 12.5.1 Sigma-Tau Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Nanoparticles Introduction
      • 12.5.4 Sigma-Tau Pharmaceuticals Revenue in Nanoparticles Business (2014-2019)
      • 12.5.5 Sigma-Tau Pharmaceuticals Recent Development
    • 12.6 Abraxis Biosciences
      • 12.6.1 Abraxis Biosciences Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Nanoparticles Introduction
      • 12.6.4 Abraxis Biosciences Revenue in Nanoparticles Business (2014-2019)
      • 12.6.5 Abraxis Biosciences Recent Development
    • 12.7 Nano Interface Technology
      • 12.7.1 Nano Interface Technology Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Nanoparticles Introduction
      • 12.7.4 Nano Interface Technology Revenue in Nanoparticles Business (2014-2019)
      • 12.7.5 Nano Interface Technology Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fine particles (between 100 and 2,500 nanometers), and coarse particles (2,500 and 10,000 nanometers).
      Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.
      The segment dominated the market as key nanoparticles such as dendrimers, inorganic nanoparticles like gold nanoparticles are used in pharmaceutical drug delivery.
      In 2017 North America dominated the global nanoparticles market. The factors like increasing incidence of chronic diseases such as cancer and diabetes in the region fueled the growth of the nanotechnology drug delivery market in North America. However, the market in Europe and Latin America is projected to expand at the highest CAGR during the forecast period.
      In 2018, the global Nanoparticles market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Nanoparticles status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanoparticles development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Gilead Sciences
      Johnson & Johnson
      Amgen
      Sigma-Tau Pharmaceuticals
      Abraxis Biosciences
      Nano Interface Technology
      ...

      Market segment by Type, the product can be split into
      Liposomes
      Polymer-Conjugated Drugs
      Polymeric Nanoparticles
      Dendrimers
      Inorganic Nanoparticles
      Others

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgery Centers
      Diagnostic Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Nanoparticles status, future forecast, growth opportunity, key market and key players.
      To present the Nanoparticles development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Nanoparticles are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now